Oaktree Acquisition Corp. III Life Sciences

Financial Services

NASDAQ:OACC · NASDAQ Global Market

Market Cap $262.05M Beta -0.04 P/E (TTM) 29.2
$10.70 +0.37%

+$0.04 today

52W Low $10.30High $10.74

Vol 0.00M · Avg 0.01M

EPS (TTM)$0.37
Shell Companies

Management

Put operating results in leadership context

Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.

Return Metrics

ROE, ROIC & ROA over time

Management

ROE

3.7%

avg 1.9%

ROIC

-0.6%

avg -0.3%

ROA

3.6%

avg 1.8%

Analysis

ROE is currently the strongest return metric at 3.7% versus its period average of 1.9%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Management

Key executives, compensation & ownership

Management
NameTitleCompensationTenureAgeShares OwnedOwnership %

George A. Martinez

Chief Financial Officer, Principal Accounting & Principal Financial Officer41$0.00<0.01%

Mathew Pendo

Chief Operation Officer62

Zaid Pardesi

Chief Executive Officer & Director43

Insider Trading

SEC Form 4 transactions — last 12 months

Management

No insider transactions in the last 12 months.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A
RevenueN/AN/AN/A
N/A
Net IncomeN/AN/AN/A
N/A
EBITN/AN/AN/A
N/A

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Who manages OACC?

Oaktree Acquisition Corp. III Life Sciences (OACC) lists 3 active executives. The top listed executive is George A. Martinez, Chief Financial Officer, Principal Accounting & Principal Financial Officer.

Are OACC insiders buying or selling?

Recent insider activity shows net buying of $339,810.00.

Explore More

Continue the stock analysis

Jump to another research area for this company.